PTK2 and esophageal squamous cell carcinoma: After the catalytically inactive DGKα Y335F mutant was transfected into ESCC cells (Fig. 7E), the CCL22-facilitated membrane recruitment of DGKα, the DGKα/FAK interaction, and subsequent FAK activation were blocked (Fig. 7F–H).